Passage Bio (PASG) EBITDA (2019 - 2026)
Passage Bio (PASG) EBITDA from Mar 31, 2019 to Mar 31, 2026. The TTM Passage Bio (PASG) EBITDA is -$40M. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual EBITDA
Quarterly EBITDA
Passage Bio (PASG) EBITDA CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | -39.06% |
| 3 Years TTM | -31.85% |
| 5 Years TTM | -21.19% |
| All Time TTM | -2.57% |
Annual EBITDA change of Passage Bio (PASG)
| Year | EBITDA | Change |
|---|---|---|
| 2026 | -$8.12M | -83.28% |
| 2025 | -$49M | -27.85% |
| 2024 | -$67M | -35.68% |
| 2023 | -$105M | -22.30% |
| 2022 | -$135M | -26.86% |
| 2021 | -$184M | +64.31% |
| 2020 | -$112M | +202.56% |
| 2019 | -$37M | N/A |
Comparison Passage Bio (PASG) five years EBITDA CAGR with competitors
Passage Bio (PASG) five years EBITDA CAGR is -21.19%.